Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-10-28
1997-12-09
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, C07K 1400, A61K 3800
Patent
active
056960930
ABSTRACT:
The invention relates to neuropeptide Y-Y.sub.2 receptor specific peptides. Preferred peptides areas follows: ##STR1## The peptides are preferably used in relieving nasal congestion.
REFERENCES:
patent: 4701441 (1987-10-01), Kalra
patent: 5026685 (1991-06-01), Boublik et al.
patent: 5395823 (1995-03-01), Kirstenansky
Potter Erica
Selbie Lisa
Tseng Albert
CRC for Biopharmaceutical Research Pty Limited
Hill Jr. Robert J.
Touzeau P. Lynn
LandOfFree
Method of treating nasal congestion using neuropeptide Y Y2 agon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating nasal congestion using neuropeptide Y Y2 agon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating nasal congestion using neuropeptide Y Y2 agon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607740